Catalyst Biosciences - Delisted Stock
Catalyst Biosciences is currently unavailable and cannot be used in your analysis. The information on this page reflects the last day Catalyst Biosciences was actively traded. Please check the stock traded under the symbol GYRE.
Catalyst Biosciences Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Catalyst Biosciences market risk premium is the additional return an investor will receive from holding Catalyst Biosciences long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Catalyst Biosciences. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Catalyst Biosciences' alpha and beta are two of the key measurements used to evaluate Catalyst Biosciences' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 40.44 | |||
| Semi Deviation | 5.45 | |||
| Standard Deviation | 165.95 | |||
| Variance | 27540.04 |
Delisting Warning - CBIO
Catalyst Biosciences was delisted
| The entity Catalyst Biosciences with a symbol CBIO was delisted from NASDAQ Exchange. Please try Gyre Therapeutics with a symbol GYRE from now on. Check all delisted instruments accross multiple markets. |
Catalyst Biosciences Corporate Directors
Catalyst Biosciences corporate directors refer to members of a Catalyst Biosciences board of directors. The board of directors generally takes responsibility for the Catalyst Biosciences' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Catalyst Biosciences' board members must vote for the resolution. The Catalyst Biosciences board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Edward Williams | Director | Profile | |
| Jeffrey Himawan | Director | Profile | |
| Harold Selick | Director | Profile | |
| Stephen Hill | Director | Profile |
Still Interested in Catalyst Biosciences?
Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Consideration for investing in Catalyst Stock
If you are still planning to invest in Catalyst Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Catalyst Biosciences' history and understand the potential risks before investing.
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |